HCW Biologics Inc. Common Stock
$1.95
Market Cap
$3.58M
Shares Outstanding
1.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 20, 2021
Round Lot
100
Locale
US
Day Open
$2.05
Day High
$2.07
Day Low
$1.94
Volume
67.7K
VWAP
$2.00
Prev Close
$2.01
Transactions
--
Acc. Volume
--
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
HCW Biologics Inc. Common Stock (HCWB) closed the 2026-09-17 session at $1.95, down 2.99% versus the previous close (-0.06). The stock opened at $2.05 and traded between $1.94 and $2.07 during that session. Session trading volume was 68K shares. The volume-weighted average price (VWAP) is $2.00.
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
HCW Biologics Inc. Common Stock has a market capitalization of $3.6 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. HCWB is listed on the XNAS exchange. The company employs approximately 35 people. HCW Biologics Inc. Common Stock is headquartered in MIRAMAR, FL. The recorded listing date is 2021-07-20.
On this page you can find market HCWB stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.